Developing Robust Media Formulations for Optimal Productivity and Product Quality
WEBINAR
Join us for an exclusive webinar on developing robust cell culture media formulations. Explore the critical role of leveraging diverse libraries and raw material characterization and gain valuable insights into data-driven development for optimal productivity and quality. From statistical design approaches to advanced explorations, this webinar will equip you with the knowledge to enhance your cell culture media development strategies. Don't miss this opportunity to stay at the forefront of bioprocessing innovation!
In this webinar, you will learn:
- The winning combination - why diverse libraries and raw materials characterization are so important
- Next-generation media development through data mining of critical biochemical components
- Case studies: CHO Fed-batch development and Perfusion considerations
- Global manufacturing supply network, and the role of cell culture media services in every step of the molecule journey.
Speakers
Jochen Sieck
Merck
R&D Director
Jochen Sieck joined Merck in 2014 as a lab head. In January 2024, he was promoted to global director of cell culture media R&D, with teams in Shanghai, Lenexa, St. Louis, and Darmstadt. His group develops catalog as well as custom cell culture media for biological manufacturing processes producing monoclonal antibodies, vaccines, viral and gene therapies, and more. A hallmark of his team’s R&D activities is close collaboration with customers in the global biopharma industry.
Rain Lee
Merck
Regional Strategy Execution Manager, Upstream APeC
Rain Lee is a Regional Strategy Execution Manager for Upstream in Asia Pacific excluding China (APeC) at Merck. She partners with biopharma customers to translate process development challenges into scalable solutions, with a focus on upstream bioprocessing innovations—including cell lines, cell culture media, and intensified processes—as well as regional manufacturing strategies. Rain leads upstream go-to-market initiatives across APeC, helping customers accelerate development, reduce risk, and confidently transit from early development to GMP production.
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
期间:1h
语言:English
场次 1:往期 October 1, 2024